Vaccination in Atherosclerosis

Area of Science:

• Cardiovascular Science
• Immunology
• Inflammation Research

Background:

• Atherosclerosis, a primary cause of global mortality, involves chronic vascular inflammation and plaque formation.
• Current anti-atherosclerosis treatments are limited, with inflammation-targeting therapies raising safety concerns regarding host defense impairment.
• Decades of research link adaptive immune responses to autoantigens in plaque development (atherogenesis).

Purpose of the Study:

• To review current vaccination strategies for atherosclerosis.
• To explore the mechanisms of action and therapeutic potential of these immunotherapies.
• To identify challenges in translating atherosclerosis vaccination into clinical practice.

Main Methods:

• Review of scientific literature and preclinical data on atherosclerosis vaccination.
• Analysis of adaptive immune responses against plaque-associated autoantigens.
• Evaluation of proposed mechanisms of action for anti-atherosclerosis vaccines.

Main Results:

• Preclinical studies suggest immunization against specific autoantigens offers protective effects.
• Vaccination strategies aim to precisely target atherosclerotic plaques, potentially avoiding host defense impairment.
• Evidence supports the role of adaptive immunity in atherogenesis, indicating potential for immunomodulation.

Conclusions:

• Vaccination represents a promising, targeted approach for atherosclerosis treatment.
• Further research is needed to overcome challenges for clinical translation of these immunotherapies.
• Developing safe and effective atherosclerosis vaccines could significantly impact cardiovascular disease prevention and treatment.